Engineering neurons for Parkinson's disease.
Lindvall
O
O
D000818:Animals; D001253:Astrocytes / Q000166:cytology / Q000378:metabolism; D017690:Cell Transplantation; D018920:Coculture Techniques; D004268:DNA-Binding Proteins; D004298:Dopamine / Q000378:metabolism*; D005818:Genetic Engineering; D006801:Humans; D008636:Mesencephalon / Q000166:cytology; D051379:Mice; D009474:Neurons / Q000166:cytology / Q000378:metabolism* / Q000637:transplantation; D057126:Nuclear Receptor Subfamily 4, Group A, Member 2; D010300:Parkinson Disease / Q000378:metabolism / Q000628:therapy*; D051381:Rats; D013234:Stem Cells / Q000166:cytology / Q000378:metabolism; D014157:Transcription Factors / Q000235:genetics; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism
D004268:DNA-Binding Proteins; C539882:NR4A2 protein, human; C539883:Nr4a2 protein, mouse; C539884:Nr4a2 protein, rat; D057126:Nuclear Receptor Subfamily 4, Group A, Member 2; D014157:Transcription Factors; D014446:Tyrosine 3-Monooxygenase; D004298:Dopamine